Mark Norman Levine, MSc, MD
Affiliations: | Oncology | McMaster University, Hamilton, ON, Canada |
Website:
https://experts.mcmaster.ca/display/mlevineGoogle:
"Mark Levine"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Key NS, Khorana AA, Kuderer NM, et al. (2019) Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901461 |
| Nauman G, Gray JC, Parkinson R, et al. (2018) Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials. Antioxidants (Basel, Switzerland). 7 |
| Young AM, Marshall A, Thirlwall J, et al. (2018) Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2018788034 |
| Polireddy K, Dong R, Reed G, et al. (2017) High Dose Parenteral Ascorbate Inhibited Pancreatic Cancer Growth and Metastasis: Mechanisms and a Phase I/IIa study. Scientific Reports. 7: 17188 |
| Schünemann HJ, Ventresca M, Crowther M, et al. (2016) Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. Bmj Open. 6: e010569 |
| Lyman GH, Bohlke K, Khorana AA, et al. (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline update 2014. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 654-6 |
| Levine MN, Parpia S, Julian J. (2014) Treating clots in cancer: moving closer to an answer? The Lancet. Haematology. 1: e6-7 |
| Ma Y, Chapman J, Levine M, et al. (2014) High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy. Science Translational Medicine. 6: 222ra18 |
| Lyman GH, Khorana AA, Kuderer NM, et al. (2013) Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2189-204 |
| Elit LM, Lee AY, Parpia S, et al. (2012) Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study. Thrombosis Research. 130: 894-900 |